These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9831386)

  • 1. A sandwich type acridinium-linked immunosorbent assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human sera.
    Baron AT; Lafky JM; Connolly DC; Peoples J; O'Kane DJ; Suman VJ; Boardman CH; Podratz KC; Maihle NJ
    J Immunol Methods; 1998 Oct; 219(1-2):23-43. PubMed ID: 9831386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women.
    Baron AT; Lafky JM; Suman VJ; Hillman DW; Buenafe MC; Boardman CH; Podratz KC; Perez EA; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1175-85. PubMed ID: 11700266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble epidermal growth factor receptor acridinium-linked immunosorbent assay.
    Lafky JM; Baron AT; Maihle NJ
    Methods Mol Biol; 2006; 327():39-47. PubMed ID: 16780211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies specific for peptide epitopes of the epidermal growth factor receptor's extracellular domain.
    Baron AT; Huntley BK; Lafky JM; Reiter JL; Liebenow J; McCormick DJ; Ziesmer SC; Roche PC; Maihle NJ
    Hybridoma; 1997 Jun; 16(3):259-71. PubMed ID: 9219036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
    Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor.
    Juliachs M; Castillo-Ávila W; Vidal A; Piulats JM; Garcia Del Muro X; Condom E; Hernández-Losa J; Teixidó C; Pandiella A; Graupera M; Casanovas O; Germà JR; Villanueva A; Viñals F
    Int J Cancer; 2013 Jul; 133(1):235-46. PubMed ID: 23292912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification and detection of DcR3, a decoy receptor in TNFR family.
    Chen J; Zhang L; Kim S
    J Immunol Methods; 2004 Feb; 285(1):63-70. PubMed ID: 14871535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated soluble c-erbB-2 antigen levels in the serum and effusions of a proportion of breast cancer patients.
    Leitzel K; Teramoto Y; Sampson E; Mauceri J; Langton BC; Demers L; Podczaski E; Harvey H; Shambaugh S; Volas G
    J Clin Oncol; 1992 Sep; 10(9):1436-43. PubMed ID: 1355522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas.
    Silva SD; Cunha IW; Younes RN; Soares FA; Kowalski LP; Graner E
    Oral Dis; 2010 Nov; 16(8):774-80. PubMed ID: 20604875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of ERBB family mRNA expression in breast carcinomas.
    Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
    Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual inhibition of ErbB1 and ErbB2 in cancer by recombinant human prolidase mutant hPEPD-G278D.
    Yang L; Li Y; Bhattacharya A; Zhang Y
    Oncotarget; 2016 Jul; 7(27):42340-42352. PubMed ID: 27286447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1).
    Liu B; Sun D; Xia W; Hung MC; Yu D
    J Natl Cancer Inst; 1997 Oct; 89(20):1524-9. PubMed ID: 9337349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Protein Levels of the Receptor Tyrosine Kinase ErbB3 in Serum.
    D'Abronzo LS; Pan CX; Ghosh PM
    Methods Mol Biol; 2018; 1655():319-334. PubMed ID: 28889394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
    Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
    Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implementation of soluble EGFR (sEGFR) as a theragnostic serum biomarker of breast, lung and ovarian cancer.
    Baron AT; Wilken JA; Haggstrom DE; Goodrich ST; Maihle NJ
    IDrugs; 2009 May; 12(5):302-8. PubMed ID: 19431095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transactivation of ErbB1 and ErbB2 receptors by angiotensin II in normal human prostate stromal cells.
    Lin J; Freeman MR
    Prostate; 2003 Jan; 54(1):1-7. PubMed ID: 12481249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.
    Stoll SW; Kansra S; Peshick S; Fry DW; Leopold WR; Wiesen JF; Sibilia M; Zhang T; Werb Z; Derynck R; Wagner EF; Elder JT
    Neoplasia; 2001; 3(4):339-50. PubMed ID: 11571634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Aptamer Linked Immobilized Sorbent Assay (ALISA) to Detect Circulatory IFN-α, an Inflammatory Protein among Tuberculosis Patients.
    Taneja V; Goel M; Shankar U; Kumar A; Khilnani GC; Prasad HK; Prasad GBKS; Gupta UD; Sharma TK
    ACS Comb Sci; 2020 Nov; 22(11):656-666. PubMed ID: 33063508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.
    Bouyain S; Longo PA; Li S; Ferguson KM; Leahy DJ
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15024-9. PubMed ID: 16203964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.